Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Detection kit for nucleoside analogue drug-resistant correlated mutation of hepatitis B viruses

A technology of hepatitis B virus and nucleoside analogs, which is applied in the field of hepatitis B virus nucleoside analog drug resistance-related mutation detection kits, can solve the problems of cumbersome operation, high cost, and unfavorable development of primary hospitals, and achieve operational The effect of simplicity, low price, good application prospects and generalizability

Active Publication Date: 2013-07-10
DAAN GENE CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most of these methods are expensive and cumbersome to operate, which is not conducive to the development of primary hospitals.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection kit for nucleoside analogue drug-resistant correlated mutation of hepatitis B viruses
  • Detection kit for nucleoside analogue drug-resistant correlated mutation of hepatitis B viruses
  • Detection kit for nucleoside analogue drug-resistant correlated mutation of hepatitis B viruses

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0093] Embodiment 1: the extraction of serum DNA

[0094] Aseptically collect about 1ml of venous blood from the hepatitis B patient to be tested, let it stand at room temperature and 4°C for 2 hours and 1 hour respectively, then centrifuge (8,000rpm, 5 minutes) to separate and collect 200μl of serum sample. Then take 40 μl of serum sample, add an equal amount of DNA extraction solution to it, mix thoroughly and place in a boiling water bath for 10 minutes. In order to ensure that the virus particles contained in the serum can be fully lysed, the mixture was further left to stand at 4° C. for 10 hours. It was then centrifuged (10,000 rpm, 5 minutes) and 2 μl of the supernatant was collected and used for further PCR reactions.

Embodiment 2

[0095] Example 2: Nested PCR amplification of a target DNA fragment comprising the region sequence of HBV DNA polymerase rt173-rt250.

[0096] Take several tubes of PCR reaction solution for one person, add 2 μl template (or negative and positive standard) directly to each tube, mix well and then centrifuge briefly (3 seconds). Then put each reaction tube into the PCR instrument, pretreatment at 50°C for 3 minutes, and amplify according to the following conditions: 93°C for 5 minutes, then 93°C for 30 seconds, 68°C for 1 minute, a total of 25 cycles, and then 93°C for 30 seconds. seconds, 55°C for 30 seconds, 72°C for 45 seconds, a total of 30 cycles, and finally 72°C for 7 minutes. Amplified products were detected by 2% agarose gel electrophoresis (see attached figure 2 ). The PCR amplification system used included: 1× qualitative PCR buffer, 0.2mM dNTPs, 6U Taq enzyme, 0.1pmol primer 1, primer 4 (SEQ ID NO:1,4) and 0.3pmol primer 2, primer 3 (SEQ ID NO: 2, 3).

Embodiment 3

[0097] Example 3: Reverse dot blot detection of samples of three genotypes by water bath hybridization

[0098] Before hybridization, adjust the temperature of the water bath shaker (or water bath) to the hybridization temperature, and take hybridization solution I (2×SSC-0.1% SDS) and hybridization solution II to preheat to 40-50°C for later use. Take several 15ml centrifuge tubes according to the number of samples to be tested, add 8-10ml hybridization solution I to each tube and preheat to 40-50°C. Then take 1000 μl hybridization solution I+2 μl solution I (1000:2) mixed solution as the binding solution and store it at 4°C for later use, and take the mixture of solution II: solution III: solution IV (1900:200:1) (1.9ml solution II+ 0.2ml of solution III + 1 μl of solution IV) is used as a chromogenic solution and stored away from light for later use.

[0099] First, add the preheated hybridization solution I into the tube until the membrane strip is covered, add the PCR pr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a detection kit for the nucleoside analogue drug-resistant correlated mutation type hepatitis B viruses, in particular to a detection kit for quickly and accurately differentiating wild type and / or nucleoside analogue drug-resistant correlated mutation type hepatitis B viruses in a clinical blood sample by using a DNA reverse dot blot technology.

Description

technical field [0001] The present invention relates to a hepatitis B virus nucleoside analog drug resistance-related mutation detection kit, in particular to using DNA reverse dot hybridization technology to rapidly and accurately distinguish wild-type and (or) nucleoside analogs in clinical blood samples Detection kit for drug resistance-related mutant hepatitis B virus. Background technique [0002] Hepatitis B virus (HBV) is the main pathogen causing viral hepatitis. Hepatitis B caused by HBV is a serious infectious disease. At present, there are at least 350 million chronic HBV-infected persons in the world, and China, as a high-incidence area of ​​hepatitis B, accounts for about 9% of the total population (about 120 million) as chronic HBV-infected persons. Persistent chronic HBV infection can be clinically manifested as various types of diseases, including asymptomatic carrier status, acute or chronic hepatitis, liver cirrhosis, etc., and severe cases may develop in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/70C12Q1/68
Inventor 张太松董瑞华陈娟李明周新宇何蕴韶
Owner DAAN GENE CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com